UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

Donald Trump's recent executive orders slashing drug prices and demanding transparency in pharmacy benefit manager fees are ...

UnitedHealth shares dropped 55%, facing lawsuits and claim rejection issues. Management changes raise questions on recovery.

Gov. Gavin Newsom announced Tuesday that he will seek to regulate prescription drug managers he blames for driving up costs ...

Perhaps it's because I've had no change in provider, haven't taken the auto-renew option, and my prescription hasn't run out. Also, I haven't tried to use the website to order as I can't sign onto ...

The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was highly similar to Stelara.

UnitedHealth Group said 2025 revenue at Optum would be $10 billion less than previously estimated. Now the company is saying ...

UnitedHealth Group said its Chief Executive, Andrew Witty, resigned today, and the company suspended its annual forecast due to surging medical costs, sending shares plunging nearly 16% to a four-year ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices ...

In a lawsuit announced last week, Bucks County officials accuse pharmacy benefit managers (PBMs) CVS Caremark, Express ...

Consolidation has also led to practices like patient steering, Joyce said. Three pharmacy benefit managers dominate the industry: CVS Caremark, Express Scripts and OptumRx represent more than 80% of ...